The therapeutic value of treatment for multiple sclerosis: analysis of health technology assessments of three European countries

In accordance with European regulation, medicines containing a new active substance to treat neurodegenerative diseases as well as autoimmune and other immune dysfunctions must be approved by the European Medicines Agency (EMA) through the centralized procedure before they can be marketed. However,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lucia Gozzo (Autor), Giovanni Luca Romano (Autor), Serena Brancati (Autor), Laura Longo (Autor), Daniela Cristina Vitale (Autor), Filippo Drago (Autor)
Formato: Libro
Publicado: Frontiers Media S.A., 2023-04-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible